Literature DB >> 16331249

Androgen receptor levels are increased by interferons in human prostate stromal and epithelial cells.

Z Basrawala1, F Alimirah, H Xin, N Mohideen, S C Campbell, R C Flanigan, D Choubey.   

Abstract

Proliferation of normal and malignant prostate epithelium is regulated by androgen stimulation via both the androgen receptor (AR)-positive stromal and epithelial cells. However, it is not known how AR expression is regulated in human prostate cells. We report that treatment of normal human prostate stromal cells (PrSCs) with type I IFN (alpha or beta), but not type II IFN (gamma), resulted in increased levels of AR protein. The maximal increase in AR protein levels was dependent on the dose and the duration of the IFN-alpha treatment. We found that the increase in AR protein levels was independent of de novo transcription and protein synthesis. Interestingly, the IFN-alpha treatment of PrSCs resulted in considerable nuclear accumulation of AR, stimulation of AR-mediated transcription of reporter genes, and retardation of cell proliferation. Furthermore, treatment of normal human prostate epithelial cells with IFNs (alpha, beta or gamma) also resulted in increased levels of AR protein. Together, our observations identify the androgen receptor as an IFN-regulated protein in normal human prostate stromal and epithelial cells and predict that IFN-induced levels of AR in prostate cells contribute to the regulation of androgen signaling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16331249     DOI: 10.1038/sj.onc.1209304

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  7 in total

1.  Low-calcium serum-free defined medium selects for growth of normal prostatic epithelial stem cells.

Authors:  Ivan V Litvinov; Donald J Vander Griend; Yi Xu; Lizamma Antony; Susan L Dalrymple; John T Isaacs
Journal:  Cancer Res       Date:  2006-09-01       Impact factor: 12.701

2.  Antitumor activity of interferon-β1a in hormone refractory prostate cancer with neuroendocrine differentiation.

Authors:  A Dicitore; E S Grassi; M O Borghi; G Gelmini; M C Cantone; G Gaudenzi; L Persani; M Caraglia; G Vitale
Journal:  J Endocrinol Invest       Date:  2017-03-01       Impact factor: 4.256

3.  PSMA-targeted polyinosine/polycytosine vector induces prostate tumor regression and invokes an antitumor immune response in mice.

Authors:  Yael Langut; Alaa Talhami; Samarasimhareddy Mamidi; Alexei Shir; Maya Zigler; Salim Joubran; Anna Sagalov; Efrat Flashner-Abramson; Nufar Edinger; Shoshana Klein; Alexander Levitzki
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-11       Impact factor: 11.205

Review 4.  Emerging roles for the interferon-inducible p200-family proteins in sex bias in systemic lupus erythematosus.

Authors:  Divaker Choubey; Ravichandran Panchanathan; Xin Duan; Hongqi Liu; Hongzhu Liu
Journal:  J Interferon Cytokine Res       Date:  2011-09-08       Impact factor: 2.607

5.  Interferon inducible antiviral MxA is inversely associated with prostate cancer and regulates cell cycle, invasion and Docetaxel induced apoptosis.

Authors:  Shanora G Brown; Ashley E Knowell; Aisha Hunt; Divya Patel; Sushma Bhosle; Jaideep Chaudhary
Journal:  Prostate       Date:  2014-10-18       Impact factor: 4.104

6.  Human Prostate Epithelial Cells Activate the AIM2 Inflammasome upon Cellular Senescence: Role of POP3 Protein in Aging-Related Prostatic Inflammation.

Authors:  Ravichandran Panchanathan; Vaikundamoorthy Ramalingam; Hongzhu Liu; Divaker Choubey
Journal:  Life (Basel)       Date:  2021-04-20

7.  The "Cross Talk" between the Receptors of Insulin, Estrogen and Progesterone in Neutrophils in the Synthesis of Maspin through Nitric Oxide in Breast Cancer.

Authors:  Karabi Ganguly Bhattacharjee; Mau Bhattacharyya; Umesh Chandra Halder; Pradipta Jana; Asru K Sinha
Journal:  Int J Biomed Sci       Date:  2012-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.